{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T03:17:51Z","timestamp":1764904671206,"version":"3.44.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.cellimm.2013.10.001","type":"journal-article","created":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T13:33:38Z","timestamp":1381498418000},"page":"111-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy"],"prefix":"10.1016","volume":"285","author":[{"given":"Miao","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi Yang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lang","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2009","series-title":"WHO Report 2009: Global Tuberculosis Control-epidemiology, Strategy, Financing","author":"World Health Organization","key":"10.1016\/j.cellimm.2013.10.001_b0005"},{"key":"10.1016\/j.cellimm.2013.10.001_b0010","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1086\/314072","article-title":"Preventing tuberculosis with bacillus Calmette-Guerin vaccine: a meta-analysis of the literature","volume":"31","author":"Brewer","year":"2000","journal-title":"Clin. Infect. Dis."},{"issue":"2003","key":"10.1016\/j.cellimm.2013.10.001_b0015","first-page":"4","article-title":"The TB epidemic from 1992 to 2002","volume":"83","author":"Raviglione","year":"2002","journal-title":"Tuberculosis (Edinb.)"},{"key":"10.1016\/j.cellimm.2013.10.001_b0020","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4161\/hv.5.2.7210","article-title":"BCG vaccines: their mechanisms of attenuation and impact on safety and protective efficacy","volume":"52","author":"Liu","year":"2009","journal-title":"Hum. Vaccines"},{"key":"10.1016\/j.cellimm.2013.10.001_b0025","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/1471-2164-9-413","article-title":"Novel genome polymorphisms in BCG vaccine strains and impact on efficacy","volume":"9","author":"Leung","year":"2008","journal-title":"BMC Genom."},{"key":"10.1016\/j.cellimm.2013.10.001_b0030","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1126\/science.284.5419.1520","article-title":"Comparative genomics of BCG vaccines by whole-genome DNA microarray","volume":"284","author":"Behr","year":"1999","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.cellimm.2013.10.001_b0035","doi-asserted-by":"crossref","first-page":"6996","DOI":"10.1128\/IAI.70.12.6996-7003.2002","article-title":"Identification of novel mycobacterium tuberculosis antigens with potential as diagnostic reagents or subunit vaccine candidates by comparative genomics","volume":"70","author":"Cockle","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cellimm.2013.10.001_b0040","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/00129785-200202030-00004","article-title":"Comparative genomics in the fight against tuberculosis: diagnostics, epidemiology, and BCG vaccination","volume":"23","author":"Mostowy","year":"2002","journal-title":"Am. J. Pharmacogenom."},{"key":"10.1016\/j.cellimm.2013.10.001_b0045","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2249.2006.03306.x","article-title":"Translational mini-review series on vaccines:development and evaluation of improved vaccines against tuberculosis","volume":"147","author":"Sander","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cellimm.2013.10.001_b0050","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1365-2567.2011.03525.x","article-title":"Robust immune response elicited by a novel and unique Mycobacterium tuberculosis protein using an optimized DNA\/protein heterologous prime\/boost protocol","volume":"135","author":"Cayabyab","year":"2011","journal-title":"Immunology"},{"issue":"8","key":"10.1016\/j.cellimm.2013.10.001_b0055","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0264-410X(01)00450-9","article-title":"Enhanced CD8+ T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes","volume":"207","author":"Gilberta","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2013.10.001_b0060","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2567.2004.01903.x","article-title":"Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Gu\u00e9rin","volume":"1123","author":"Martin Vordermeier","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.cellimm.2013.10.001_b0065","doi-asserted-by":"crossref","first-page":"e5139","DOI":"10.1371\/journal.pone.0005139","article-title":"CD4+ and CD8+ T cell responses to the M. tuberculosis Ag85B-TB10.4 promoted by adjuvanted subunit, adenovector or heterologous prime boost vaccination","volume":"44","author":"Elvang","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.cellimm.2013.10.001_b0070","doi-asserted-by":"crossref","first-page":"e816","DOI":"10.1016\/j.ijid.2012.07.008","article-title":"Immunogenicity and protective efficacy of heterologous prime-boost regimens with mycobacterial vaccines and recombinant adenovirus- and poxvirus-vectored vaccines against murine tuberculosis","volume":"16","author":"You","year":"2012","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.cellimm.2013.10.001_b0075","first-page":"341","article-title":"New vaccines against tuberculosis","volume":"10","author":"Mart\u00edn","year":"2007","journal-title":"Tuberculosis"},{"key":"10.1016\/j.cellimm.2013.10.001_b0080","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1590\/S1413-86702008000600008","article-title":"CD4+ cell counts in patients with different clinical manifestations of tuberculosis","volume":"12","author":"Davoudi","year":"2008","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.cellimm.2013.10.001_b0085","first-page":"1194","article-title":"Increased production of interleukin 4 by CD4+ and CD8+T cells from patients with tuberculosis is related to the presence of pulmonary cavities","volume":"2000","author":"van Crevel","year":"1813","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cellimm.2013.10.001_b0090","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1128\/IAI.67.8.3980-3988.1999","article-title":"Early emergence of cd8+t cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice","volume":"678","author":"Serbina","year":"1999","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.cellimm.2013.10.001_b0095","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.tube.2003.08.018","article-title":"Inactivation of the Mycobacterium bovis homologue of the polymorphic RD1 gene Rv3879c (Mb3909c) does not affect virulence","volume":"83","author":"Inwald","year":"2003","journal-title":"Tuberculosis"},{"key":"10.1016\/j.cellimm.2013.10.001_b0100","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1128\/IAI.74.4.2128-2137.2006","article-title":"An increase in antimycobacterial Th1-Cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis","author":"Majlessi","year":"2006","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.cellimm.2013.10.001_b0105","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1128\/IAI.01660-05","article-title":"Immunogenicity of Mycobacterium tuberculosis antigens in Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle","volume":"74","author":"Mustafa","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cellimm.2013.10.001_b0110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00005-009-0055-4","article-title":"Serodiagnostic efficacy of Mycobacterium tuberculosis 30\/32-kDa mycolyl transferase complex, ESAT-6, and CFP-10 in patients with active tuberculosis","volume":"58","author":"Kumar","year":"2010","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.cellimm.2013.10.001_b0115","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s00284-006-0466-y","article-title":"High-level production of a novel antimicrobial peptide perinerin in Escherichia coli by fusion expression","volume":"54","author":"Zhou","year":"2007","journal-title":"Curr. Microbiol."},{"key":"10.1016\/j.cellimm.2013.10.001_b0120","first-page":"371","article-title":"6\u2217His-Ni-NTA chromatography as a superior technique in recombinant protein expression\/purification","volume":"31","author":"Crowe","year":"1994","journal-title":"Protoc. Gene Anal. Methods Mol. Biol."},{"key":"10.1016\/j.cellimm.2013.10.001_b0125","article-title":"Immunogenicity and protective efficacy against murine tuberculosis of a prime-boost regimen with BCG and a DNA vaccine expressing ESAT-6 and Ag85A fusion protein","author":"Jia","year":"2011","journal-title":"Clin. Dev. Immun."},{"key":"10.1016\/j.cellimm.2013.10.001_b0130","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1128\/IAI.69.5.3041-3047.2001","article-title":"Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting","volume":"69","author":"Tanghe","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cellimm.2013.10.001_b0135","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1128\/IAI.70.3.1623-1626.2002","article-title":"Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8+ and CD4+ T-cell epitopes from antigen 85A","volume":"70","author":"McShane","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cellimm.2013.10.001_b0140","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.vaccine.2005.08.076","article-title":"DNA vaccines in sheep: CTLA-4 mediated targeting and CpG motifs enhance immunogenicity in a DNA prime\/protein boost strategy","volume":"24","author":"Kennedy","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2013.10.001_b0145","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1128\/IAI.69.4.2714-2717.2001","article-title":"Boosting vaccine for tuberculosis","volume":"69","author":"Brooks","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cellimm.2013.10.001_b0150","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/eji.201040455","article-title":"Multifunctional CD4+ T cells correlate with active Mycobacterium tuberculosis infection","volume":"40","author":"Caccamo","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cellimm.2013.10.001_b0155","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1164\/rccm.2204027","article-title":"CD8+ T cells in tuberculosis","volume":"166","author":"Lazarevic","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cellimm.2013.10.001_b0160","first-page":"68s","article-title":"Functions of T-cell subsets and cytokines in mycobacterial infections","volume":"20","author":"Munk","year":"1995","journal-title":"Eur. Respir. J. Suppl."},{"key":"10.1016\/j.cellimm.2013.10.001_b0165","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.4049\/jimmunol.176.7.4296","article-title":"Contribution of CD8+ T cells to control of Mycobacterium tuberculosis infection","volume":"176","author":"Sud","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2013.10.001_b0170","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.micinf.2005.03.009","article-title":"Prime-boost immunisation strategies for tuberculosis","volume":"7","author":"McShane","year":"2005","journal-title":"Microbes Infect."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874913001676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874913001676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T22:51:48Z","timestamp":1757803908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874913001676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":34,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0008874913001676"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2013.10.001","relation":{},"ISSN":["0008-8749"],"issn-type":[{"type":"print","value":"0008-8749"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2013.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}